Suchergebnisse - (Subject:"O3J8G9O825")

PubPharm (5.444)

1

Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers

enthalten in: Clinical pharmacokinetics | 2024

von Rohr, B. | Krohmer, E. | Foerster, K. | +5

2

Proof-of-concept studies with a computationally designed Mpro inhibitor as a synergistic combination regimen alternative to Paxlovid

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2024

von Papini, C. | Ullah, I. | Ranjan, A. | +11

3

Clinical assessment of momelotinib drug-drug interactions via CYP3A metabolism and transporters

enthalten in: Clinical and translational science | 2024

von Ho, Y. | Gorycki, P. | Ferron-Brady, G. | +2

4

A combination of nirmatrelvir and ombitasvir boosts inhibition of SARS-CoV-2 replication

enthalten in: Antiviral research | 2024

von Moon, C. | Porges, E. | Roberts, A. | +1

5

Review : The Landscape of Antiviral Therapy for COVID-19 in the Era of Widespread Population Immunity and Omicron-Lineage Viruses

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Meyerowitz, E. | Li, Y.

6

Development of lipid-based SEDDS using digestion products of long-chain triglyceride for high drug solubility : Formulation and dispersion testing

enthalten in: International journal of pharmaceutics | 2024

von Desai, H. | T M Serajuddin, A.

7

Effectiveness of nirmatrelvir-ritonavir versus azvudine for adult inpatients with severe or critical COVID-19

enthalten in: BMJ open respiratory research | 2024

von Zhang, H. | Xiaojiao, T. | Chen, J. | +8

8

Mild SARS-CoV-2 infection in vulnerable patients : implementation of a clinical pathway for early treatment

enthalten in: Enfermedades infecciosas y microbiologia clinica (English ed.) | 2024

von Pinargote-Celorio, H. | Otero-Rodríguez, S. | González-de-la-Aleja, P. | +11

9

A global phase II randomized trial comparing oral taxane ModraDoc006/r to intravenous docetaxel in metastatic castration resistant prostate cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Vaishampayan, U. | Keessen, M. | Dreicer, R. | +11

10

COVID-19 hospitalization risk after outpatient nirmatrelvir/ritonavir use, January to August 2022, North Carolina

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Henderson, H. | Wohl, D. | Fischer, W. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[545]